Vitality Watch

Dossier pubmed observational 05-dec-2025
Human cohort, case-control, or epidemiological association

The immuno-neurological axis: association between autoimmune diseases and dementia risk.

Key claim: Autoimmune diseases were associated with a ~32% higher risk of dementia (especially Alzheimer’s) and higher odds of positive cognitive-impairment screening in a large Korean national cohort.

Abstract

Dementia is a growing global public health concern, with an increasing number of individuals affected due to the aging population. Although chronic inflammation is implicated in cognitive impairment, studies on its association with autoimmune diseases, which are representative chronic inflammatory diseases, are lacking. This study aimed to investigate whether the onset of autoimmune diseases is associated with an increased risk of dementia or cognitive impairment. This study used data from the Korean National Health Insurance Service-Health Screening from 2002 to 2019, with 8,743,801 person-years. The risk of dementia according to the type of autoimmune disease was calculated using the Cox proportional hazards model. The status and risk of cognitive impairment, which were assessed using the Korean Dementia Screening Questionnaire-Prescreening related with autoimmune diseases also estimated. Among participants, 8.3% developed dementia. All autoimmune diseases significantly increased dementia risk (hazard ratio [HR] 1.32; 95% confidence interval [CI] 1.29-1.35), particularly Alzheimer’s disease (HR 1.36; 95% CI, 1.32-1.40), vascular dementia (HR, 1.21; 95% CI, 1.12-1.30), and unspecified dementia (HR, 1.25; 95% CI, 1.18-1.33). Autoimmune diseases also increased the risk of positive dementia screening (odds ratio [OR], 1.18; 95% CI, 1.12-1.24), particularly connective tissue disorders (OR, 1.24; 95% CI, 1.15-1.34). This large-scale cohort study demonstrates a significant association between autoimmune diseases and increased risk of dementia and cognitive impairment. These findings underscore the potential importance of chronic inflammation in dementia pathogenesis and highlight the need for early cognitive screening and intervention strategies in patients with autoimmune diseases.

Why this matters

A large national cohort converts the previously mostly mechanistic autoimmunity–neuroinflammation–dementia idea into a quantified human-observational association, with autoimmune diagnosis carrying ~32% higher dementia risk and subtype-specific hazard ratios. It strengthens the case that systemic autoreactive immune activity is one of the downstream clinical signatures of inflammaging and immunosenescence rather than an orthogonal disease category. It does not identify a mediator, test an intervention, or establish causality.

Source

Link

Briefing card

The immuno-neurological axis: association between autoimmune diseases and dementia risk.
Stage: observational · pubmed · 05-dec-2025

If you have an autoimmune disease, this Korean cohort found ~32% higher associated dementia risk — an association, not a causal or treatment claim.

Autoimmune diseases were associated with a ~32% higher risk of dementia (especially Alzheimer’s) and higher odds of positive cognitive-impairment screening in a large Korean national cohort.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11357-025-01904-2

build build 880 · 2bcef25 · 2026-11-18